Drug Safety Monitoring for the 21st Century

By

Jacob Goldstein

Apr 15, 2008 10:01 am ET

For all the health data sitting on computers in this country, our drug safety surveillance is remarkably primitive, relying on clinical trials (which capture a tiny percentage of those taking prescription drugs) and sporadic reports from doctors and drugmakers. A deal being announced today could change that. The FDA will contract with WellPoint, the country’s […]